Cargando…

Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany

Seasonal influenza causes many cases and related deaths in Europe annually, despite ongoing vaccination programs for older adults and people at high-risk of complications. Children have the highest risk of infection and play a key role in disease transmission. Our cost-utility analysis, based on a d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Molnar, Daniel, Anastassopoulou, Anastassia, Poulsen Nautrup, Barbara, Schmidt-Ott, Ruprecht, Eichner, Martin, Schwehm, Markus, Dos Santos, Gael, Ultsch, Bernhard, Bekkat-Berkani, Rafik, von Krempelhuber, Alfred, Van Vlaenderen, Ilse, Van Bellinghen, Laure-Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Influenza – Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248945/ https://www.ncbi.nlm.nih.gov/pubmed/35486410 http://dx.doi.org/10.1080/21645515.2022.2058304

Ejemplares similares

Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model
por: Dolk, Christiaan, et al.
Publicado: (2016)

Assessing direct and indirect effects of pediatric influenza vaccination in Germany by individual-based simulations
por: Schmidt-Ott, Ruprecht, et al.
Publicado: (2019)

Enhanced passive safety surveillance of the MF59-adjuvanted quadrivalent influenza vaccine in the elderly during the 2021/22 influenza season
por: Amicizia, Daniela, et al.
Publicado: (2023)

Immunogenicity and safety of quadrivalent inactivated influenza vaccine in children aged 6 to 35 months: A systematic review and meta-analysis
por: Wei, Xia, et al.
Publicado: (2023)

An approximation of herd effect due to vaccinating children against seasonal influenza – a potential solution to the incorporation of indirect effects into static models
por: Van Vlaenderen, Ilse, et al.
Publicado: (2013)

Immunogenicity and safety of the quadrivalent inactivated split-virion influenza vaccine in populations aged ≥ 3 years: A phase 3, randomized, double-blind, non-inferiority clinical trial
por: Chen, Jianmin, et al.
Publicado: (2023)

4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany
por: Eichner, Martin, et al.
Publicado: (2014)

The Potential Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in Elderly People and Clinical Risk Groups in the UK: A Lifetime Multi-Cohort Model
por: Van Bellinghen, Laure-Anne, et al.
Publicado: (2014)

A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control
por: Ray, Riju, et al.
Publicado: (2017)

Reply letter to “Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial”
por: Hadigal, Sanjay, et al.
Publicado: (2022)

Cost-effectiveness of the recombinant zoster vaccine in the German population aged ≥60 years old
por: Van Oorschot, Desirée, et al.
Publicado: (2018)

Cost-utility of quadrivalent versus trivalent influenza vaccine in Brazil – comparison of outcomes from different static model types
por: Van Bellinghen, Laure-Anne, et al.
Publicado: (2018)

Antibody responses against heterologous H5N1 strains for an MF59-adjuvanted cell culture–derived H5N1 (aH5n1c) influenza vaccine in adults and older adults
por: Frey, Sharon S., et al.
Publicado: (2023)

Estimating the impact of influenza vaccination of low-risk 50–64-year-olds on acute and ICU hospital bed usage in an influenza season under endemic COVID-19 in the UK
por: Nguyen, Van Hung, et al.
Publicado: (2023)

A Chimeric Vaccine against Porcine Circovirus Type 2: Meta-Analysis of Comparative Clinical Trials
por: Poulsen Nautrup, Barbara, et al.
Publicado: (2023)

Switching from trivalent to quadrivalent inactivated influenza vaccines in Uruguay: a cost-effectiveness analysis
por: Bianculli, Pablo Manuel, et al.
Publicado: (2022)

Can Reactive School Closures help critical care provision during the current influenza pandemic?
por: House, Thomas, et al.
Publicado: (2009)

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India
por: Kalappanavar, Nijalingappa K., et al.
Publicado: (2022)

Influenza: Can we cope better with the unpredictable?
por: Dos Santos, Gaël, et al.
Publicado: (2015)

Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: A systematic review
por: Dos Santos, Gael, et al.
Publicado: (2018)

The Early Transmission Dynamics of H1N1pdm Influenza in the United Kingdom
por: Ghani, Azra, et al.
Publicado: (2010)

Do High Levels of Maternally Derived Antibodies Interfere with the Vaccination of Piglets against Porcine Circovirus Type 2? A Literature Review and Data Analysis
por: Poulsen Nautrup, Barbara, et al.
Publicado: (2021)

987. Repeated Exposure to an Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV): A Randomized, Observer Blind, Multicenter Study
por: Daly, Wendy, et al.
Publicado: (2018)

Public health and budget impacts of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Paraguay
por: Arbo, Antonio, et al.
Publicado: (2022)

Immunogenicity and safety of two quadrivalent influenza vaccines in healthy adult and elderly participants in India - A phase III, active-controlled, randomized clinical study
por: Basu, Indraneel, et al.
Publicado: (2021)

The 2009 pandemic H1N1 influenza vaccination in France: who accepted to receive the vaccine and why?
por: Raude, Jocelyn, et al.
Publicado: (2010)

Identification of Influenza Cases During the H1N1 Pandemic in Massachusetts Using Population-Based Hospital Discharge Data
por: Placzek, Hilary, et al.
Publicado: (2011)

Applying a New Model for Sharing Population Health Data to National Syndromic Influenza Surveillance: DiSTRIBuTE Project Proof of Concept, 2006 to 2009
por: Olson, Donald R, et al.
Publicado: (2011)

Prevalence and risk factors for swine influenza virus infection in the English pig population
por: Mastin, Alexander, et al.
Publicado: (2011)

Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo
por: Fedichev, Peter, et al.
Publicado: (2011)

Top-hits for H1N1pdm Identified by Virtual Screening Using Ensemble-based Docking
por: Nguyen, Hung, et al.
Publicado: (2011)

The severity of pandemic H1N1 influenza in the United States, April – July 2009
por: Presanis, Anne M, et al.
Publicado: (2010)

Next Generation Syndromic Surveillance: Molecular Epidemiology, Electronic Health Records and the Pandemic Influenza A (H1N1) Virus
por: Rabadan, Raul, et al.
Publicado: (2009)

Molecular modeling of swine influenza A/H1N1, Spanish H1N1, and avian H5N1 flu N1 neuraminidases bound to Tamiflu and Relenza
por: Le, Ly, et al.
Publicado: (2011)

Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza
por: Ross, Ted, et al.
Publicado: (2010)

Recrudescent wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: Age shift and severity
por: Chowell, Gerardo, et al.
Publicado: (2012)

Recovery of H14 influenza A virus isolates from sea ducks in the Western Hemisphere
por: Nolting, Jacqueline, et al.
Publicado: (2012)

Influenza activity in Saint Joseph, Missouri 1910-1923: Evidence for an early wave of the 1918 pandemic
por: Hoffman, Brian L.
Publicado: (2011)

Prevalence of antibodies against seasonal influenza A and B viruses during the 2009-2010 and 2010-2011 influenza seasons in residents of Pittsburgh, PA, USA.
por: Ross, Ted M., et al.
Publicado: (2011)

Swine to human transmission of reassortants of pandemic (H1N1) 2009 and endemic swine influenza viruses: Abstract
por: de Silva, U. Chandimal, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_bghmtcjjhq3k79sm6kqbe8lmvb